BioSpace News Archive

Bryn Pharma Announces Completion of its Pivotal Study Comparing UTULY ™ Epinephrine Intranasal Spray vs. 0.3 mg Epinephrine Autoinjector for the Treatment of Anaphylaxis.

Abiomed (Nasdaq: ABMD) will highlight how Impella heart pumps help heart teams achieve more complete high-risk revascularization and heart recovery in the catheterization lab and operating room at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference, held in Boston from September 16 to 19.

Biofrontera Inc. announces the appointment of Gerard DiGirolamo as National Sales Director.

Nuvectis Pharma, Inc. today announced positive data for NXP800 in a preclinical xenograft model of ARID1a-mutated gastric carcinoma.

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today positive Phase 2 results from its double-blind, fully randomized, placebo-controlled, multicenter trial to assess the safety and efficacy of its oral insulin candidate (ORMD-0801).

Veracyte, Inc. (Nasdaq: VCYT) announced today that John Leite, Ph.D., has joined the company as senior vice president and general manager of Pulmonology & Market Access.

Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Pemetrexed Injection (Solution) to its line of chemotherapy drugs.

Healium Medical (“Healium”), innovating a proprietary Dual-Mode Ultrasound Technology (DMUT) for the treatment of cardiac arrhythmias announced today a new collaboration and licensing agreement with Broncus Holding Corporation (2216.HK; “Broncus”).

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Overland Park Regional Medical Center (OPRMC) is establishing its second robotic program for the treatment of heart rhythm disorders.

Suvoda LLC today announced its new free-picking capabilities included in its latest Interactive Response System (IRT) release, used for patient randomization and supply chain management, at the 12th Annual DPHARM Disruptive Innovations Conference in Boston.